pharmaphorum April 19, 2023
Netherlands-based investment group Gilde Healthcare has raised €600 million ($658 million) for a new transatlantic fund intended to support innovative ventures in digital healthcare, medtech, and therapeutics.
The Venture & Growth VI fund – backed by a broad range of international investors – will focus on “fast growing companies developing solutions for better care at lower cost,” according to the company, which says it takes the total raised in the last three years to €1.5 billion.
Among its previous investments are French healthtech company Withings, which develops wearable devices for patient data collection, as well as Dutch cancer medicines developer Lava Therapeutics and Belgian antibody specialist Ablynx.
The company is also known for its private equity business focusing on profitable...
Today's Sponsors
Today's Sponsor